Healthcare Industry News: BIOLASE
News Release - September 29, 2006
BIOLASE Receives Notice That It Has Adequately Addressed the Concerns Raised in the FDA Warning LetterThe Company Believes the FDA Issues Have Been Fully Resolved
IRVINE, CA--(Healthcare Sales & Marketing Network)--Sep 29, 2006 -- BIOLASE Technology, Inc. (NASDAQ:BLTI ), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that it received a letter from the FDA stating that the FDA had completed its review of the Company's response to the Warning Letter dated September 5, 2006. The FDA reported that the Company's response adequately addressed the FDA's concerns. As a result, the Company believes the issues have been fully resolved.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.BIOLASE.com) is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. The Company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the WaterlaseŽ system, is one of the best selling dental laser systems. The Waterlase system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The Company also offers the LaserSmile(TM) system, which uses a laser to perform soft tissue and cosmetic procedures, including teeth whitening. The Company is also developing a laser for use in the field of ophthalmology.
This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.
Source: BIOLASE Technology
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.